Related references
Note: Only part of the references are listed.DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease
David G. Standaert et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2021)
Frequency of non-motor symptoms and their impact on the quality of life in patients with Parkinson's disease: a prospective descriptive case series
Aydin Gulunay et al.
PSYCHOGERIATRICS (2020)
Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study
Kanako Kurihara et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
The impact of levodopa therapy-induced complications on quality of life in Parkinson's disease patients in Singapore
Jonathan Wu et al.
SCIENTIFIC REPORTS (2019)
Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel
K. Ray Chaudhuri et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
International Parkinson and Movement Disorder Society Evidence-Based Medicine Review: Update on Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2018)
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients
Matej Skorvanek et al.
PARKINSONISM & RELATED DISORDERS (2018)
Changes in Quality of Life in Parkinson's Disease: How Large Must They Be to Be Relevant?
Krisztina Horvath et al.
NEUROEPIDEMIOLOGY (2017)
Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study
Annamaria Juhasz et al.
PARKINSONISM & RELATED DISORDERS (2017)
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease
David G. Standaert et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
Angelo Antonini et al.
MOVEMENT DISORDERS (2016)
Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups
K. Berganzo et al.
NEUROLOGIA (2016)
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
Hubert H. Fernandez et al.
MOVEMENT DISORDERS (2015)
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries
Marlene C. Hechtner et al.
PARKINSONISM & RELATED DISORDERS (2014)
Which dyskinesia scale best detects treatment response?
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2013)
Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
Christine Daniels et al.
MOVEMENT DISORDERS (2011)
Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease?
T. Ellis et al.
PARKINSONISM & RELATED DISORDERS (2011)
Health-related quality of life and its determinants in Parkinson's disease: Results of an Italian cohort study
Yaroslav Winter et al.
PARKINSONISM & RELATED DISORDERS (2011)
Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study
Yaroslav Winter et al.
JOURNAL OF NEUROLOGY (2010)
Quality of life in Parkinson's disease: The relative importance of the symptoms
Shibley Rahman et al.
MOVEMENT DISORDERS (2008)
Impact of the motor complications of Parkinson's disease on the quality of life
S Chapuis et al.
MOVEMENT DISORDERS (2005)
Practice parameter: Initiation of treatment for Parkinson's disease: An evidence-based review - Report of the quality standards subcommittee of the American Academy of Neurology
JM Miyasaki et al.
NEUROLOGY (2002)
What contributes to quality of life in patients with Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Share Paper
